Lisa A. Elferink
Affiliations: | University of Texas Medical Branch, Galveston, TX |
Area:
Molecular Biology, Cell BiologyGoogle:
"Lisa Elferink"Children
Sign in to add traineeDavid J. Strick | grad student | 2005 | UTMB |
Kristin S. Hill | grad student | 2011 | UTMB |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gaziova I, Jackson D, Boor PJ, et al. (2016) The MET Receptor Tyrosine Kinase Confers Repair of Murine Pancreatic Acinar Cells following Acute and Chronic Injury. Plos One. 11: e0165485 |
Gaziova I, Davey RA, Elferink LA. (2015) Identification of factors regulating MET receptor endocytosis by high-throughput siRNA screening. Methods in Molecular Biology (Clifton, N.J.). 1270: 381-94 |
Tao X, Hill KS, Gaziova I, et al. (2014) Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice. Oral Oncology. 50: 104-12 |
Garnett J, Chumbalkar V, Vaillant B, et al. (2013) Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells. Neoplasia (New York, N.Y.). 15: 73-84 |
Hill KS, Gaziova I, Harrigal L, et al. (2012) Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancer. Plos One. 7: e40420 |
Chen Z, Kolokoltsov AA, Wang J, et al. (2012) GRB2 interaction with the ecotropic murine leukemia virus receptor, mCAT-1, controls virus entry and is stimulated by virus binding. Journal of Virology. 86: 1421-32 |
Elferink LA, Resto VA. (2011) Receptor-tyrosine-kinase-targeted therapies for head and neck cancer. Journal of Signal Transduction. 2011: 982879 |
Sastry SK, Elferink LA. (2011) Checks and balances: interplay of RTKs and PTPs in cancer progression. Biochemical Pharmacology. 82: 435-40 |
Hill KS, Lorinczi M, Elferink LA. (2010) Altered down regulation of the receptor tyrosine kinase met in pancreatic adenocarcinoma cells. Journal of Experimental Therapeutics & Oncology. 8: 297-312 |
Ying H, Zheng H, Scott K, et al. (2010) Mig-6 controls EGFR trafficking and suppresses gliomagenesis. Proceedings of the National Academy of Sciences of the United States of America. 107: 6912-7 |